Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023
Mesa Laboratories, Inc. (NASDAQ:MLAB) plans to release its financial results for the fourth quarter and fiscal year ending March 31, 2023, on May 25, 2023, at 8:00 A.M.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Mesa Laboratories, Inc. (NASDAQ:MLAB) plans to release its financial results for the fourth quarter and fiscal year ending March 31, 2023, on May 25, 2023, at 8:00 A.M. Eastern time. The company is recognized as a global leader in designing and manufacturing life science tools and critical quality control solutions, targeting regulated applications in sectors like pharmaceuticals, healthcare, and medical devices.
Mesa operates through four divisions: Sterilization and Disinfection Control, Biopharmaceutical Development, Clinical Genomics, and Calibration Solutions, focusing on product integrity and patient safety.
Details
News Market Reaction – MLAB
The recorded move for MLAB in the trading session of this news was +0.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKEWOOD, Colo., March 09, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2023 at approximately 8:00 A.M. Eastern time on Thursday, May 25, 2023.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Clinical Genomics, and Calibration Solutions) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
For more information about the Company, please visit its website at www.mesalabs.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.